checkAd
    Burning Rock Biotech (A) (A) Aktie
    0,6900
     
    EUR
    +0,73 %
    +0,0050 EUR
    Letzter Kurs 09:59:02 Frankfurt
    0,7350
     
    EUR
    4.082 STK
    Geldkurs 15:42:13
    0,8050
     
    EUR
    3.727 STK
    Briefkurs 15:55:10
    ISIN: US12233L1070 · WKN: A2P6R5 · SYM: 6BUA · Kaiman-Inseln

    Neueste Nachrichten

    Burning Rock Publishes 2023 Annual Report on Form 20-F
    29.04.24 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock Announces ADS Ratio Change
    26.04.24 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
    28.03.24 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock Announces Receipt of Notification from NASDAQ
    04.01.24 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock Announces Results of 2023 Annual General Meeting
    20.12.23 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock Reports Third Quarter 2023 Financial Results
    30.11.23 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
    22.11.23 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
    21.11.23 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
    30.10.23 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
    16.10.23 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell
    08.09.23 · globenewswire · Burning Rock Biotech (A) (A)
    Burning Rock Reports Second Quarter 2023 Financial Results
    31.08.23 · globenewswire · Burning Rock Biotech (A) (A)